BiotechTube
Home/PepGen/Hayley Parker
HP

Hayley Parker

Senior Vice President, Global Regulatory Affairs & Quality

PepGen

Therapeutic Areas

Neuromuscular DiseasesNeurological Diseases

PepGen Pipeline

DrugIndicationPhase
PGN-EDODM1Myotonic Dystrophy Type 1 (DM1)Phase 2
PGN-EDO51Duchenne Muscular Dystrophy (DMD) amenable to Exon 51 SkippingPhase 2

Leadership Team at PepGen

JM
James McArthur
President and Chief Executive Officer
ND
Noel Donnelly
Chief Financial Officer
KK
Kasra Kasraian
Chief Technical Officer
JV
Joseph Vittiglio
Chief Business and Legal Officer
PS
Paul Streck
Executive Vice President, Head of Research & Development
EB
Emiko Bryant
Senior Vice President, HR and Administration
JL
Jane Larkindale
Vice President, Clinical Science
PL
Pallavi Lonkar
Vice President, Head of Preclinical
RL
Rod Lozano
Vice President, Information Technology
DS
Debra Sawyer
Vice President, Quality Assurance
View full PepGen profile